Clinical Trials Directory

Trials / Completed

CompletedNCT02446496

A Bioequivalence Study of Cefadroxil Film Coated Tablets After A Single Oral Dose Administration to Healthy Subjects

Comparative Randomized, Single Dose, Two-way Crossover, Open-label Study to Determine the Bioequivalence of Cefadroxil From Duricef 1 gm Film Coated Tablets (Smithkline Beecham Egypt, LLC Affiliated Co. to GalaxoSmithKline ) and Biodroxil 1 gm Film Coated Tablets (Kahira Pharm &Chem .Ind. Co. for Novartis Pharma ) After a Single Oral Dose Administration of Each to Healthy Adults Under Fasting Conditions

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
24 (actual)
Sponsor
GlaxoSmithKline · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

This is an open-label, randomized, single dose, two-sequence two-period crossover study, separated by 7 days washout interval from the first Study Drug Administration. This study is conducted to determine the bioequivalence of cefadroxil from DURICEF™ film coated tablets manufactured by Smithkline Beecham Egypt, LLC affiliated co. to GalaxoSmithKline (GSK) and cefadroxil from BIODROXIL™ film coated tablets manufactured by Kahira Pharm \&Chem .Ind. Co . for Novartis Pharma (NP) after a single oral dose administration of each to healthy adult subjects under fasting conditions. In Period 1, subjects will be randomized to receive cefadroxil tablet manufactured by either GSK or NP. Following a washout of at least 7 days, subjects will be crossed over in Period 2 to receive the cefadroxil tablet that they did not receive in Period 1. DURICEF is a trademark of the GSK group of companies. BIODROXIL is a trademark of Sandoz.

Conditions

Interventions

TypeNameDescription
DRUGCefadroxil tablets manufactured by GSKCefadroxil tablets manufactured by GSK contains 1 mg of Cefadroxil
DRUGCefadroxil tablets manufactured by NPCefadroxil tablets manufactured by NP contains 1 mg of Cefadroxil

Timeline

Start date
2014-03-31
Primary completion
2014-04-08
Completion
2014-04-08
First posted
2015-05-18
Last updated
2017-09-21
Results posted
2017-04-25

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02446496. Inclusion in this directory is not an endorsement.